Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Payne

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 6, 2020
Impact of High-Dose-Rate and Low-Dose-Rate Brachytherapy Boost on Toxicity, Functional and Cancer Outcomes in Patients Receiving External Beam Radiation Therapy for Prostate Cancer: A National Population-Based StudyMatthew G Parry, Julie Nossiter, Arunan Sujenthiran, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2023
A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancerChristian D Fankhauser, Matthew G Parry, Adnan Ali, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastiaChristopher J Tyrrell, Heather Payne, Teuvo L J Tammela, et al.
Prostate Cancer and Prostatic Diseases|January 10, 2022
Comparison of the treatment of men with prostate cancer between the US and England: an international population-based studyMatthew G Parry, Julie Nossiter, Melanie Morris, et al.
The Journal of Urology|September 28, 2002
Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I studyTimothy R Nathan, Douglas E Whitelaw, Stanley C Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 20, 2021
A Phase II, Open-label study to assess safety and management change using <sup>68</sup>Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED studyAsim Afaq, Heather Payne, Reena Davda, et al.
BJU International|April 13, 2007
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomyChris Parker, Matthew R Sydes, Charles Catton, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT TrialPeter Meidahl Petersen, Adrian D Cook, Matthew R Sydes, et al.
European Urology Focus|July 30, 2017
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional SurveyDavid Lorente, Praful Ravi, Niven Mehra, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2023
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trialSamuel Tremblay, Mofarej Alhogbani, Andrew Weickhardt, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
International Journal of Radiation Oncology, Biology, Physics|December 6, 2020
Impact of High-Dose-Rate and Low-Dose-Rate Brachytherapy Boost on Toxicity, Functional and Cancer Outcomes in Patients Receiving External Beam Radiation Therapy for Prostate Cancer: A National Population-Based StudyMatthew G Parry, Julie Nossiter, Arunan Sujenthiran, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2023
A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancerChristian D Fankhauser, Matthew G Parry, Adnan Ali, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastiaChristopher J Tyrrell, Heather Payne, Teuvo L J Tammela, et al.
Prostate Cancer and Prostatic Diseases|January 10, 2022
Comparison of the treatment of men with prostate cancer between the US and England: an international population-based studyMatthew G Parry, Julie Nossiter, Melanie Morris, et al.
The Journal of Urology|September 28, 2002
Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I studyTimothy R Nathan, Douglas E Whitelaw, Stanley C Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 20, 2021
A Phase II, Open-label study to assess safety and management change using <sup>68</sup>Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED studyAsim Afaq, Heather Payne, Reena Davda, et al.
BJU International|April 13, 2007
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomyChris Parker, Matthew R Sydes, Charles Catton, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT TrialPeter Meidahl Petersen, Adrian D Cook, Matthew R Sydes, et al.
European Urology Focus|July 30, 2017
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional SurveyDavid Lorente, Praful Ravi, Niven Mehra, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2023
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trialSamuel Tremblay, Mofarej Alhogbani, Andrew Weickhardt, et al.
Pageof 12